WallStreetZenWallStreetZen

NASDAQ: PTCT
Ptc Therapeutics Inc Stock Ownership - Who owns Ptc Therapeutics?

Insider buying vs selling

Have Ptc Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Matthew B. KleinCHIEF EXECUTIVE OFFICER2024-04-193,361$24.89
$83.67kSell
Matthew B. KleinCHIEF EXECUTIVE OFFICER2024-04-171,307$25.14
$32.85kSell
Eric PauwelsCHIEF EXECUTIVE OFFICER2024-04-17787$25.14
$19.78kSell
Lee Scott GoldenEVP CHIEF MEDICAL OFFICER2024-04-02526$28.37
$14.92kSell
Eric PauwelsCHIEF BUSINESS OFFICER2024-01-30366$27.25
$9.97kSell
Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER2024-01-30618$27.25
$16.84kSell
Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER2024-01-3028$27.25
$763.03Sell
Christine Marie UtterSVP CHIEF ACCOUNTING OFFICER2024-01-30318$27.25
$8.67kSell
Mark Elliott BouldingEXEC. VP AND CLO2024-01-30794$27.25
$21.64kSell
Allan Steven JacobsonDirector2024-01-2210,000$27.05
$270.50kBuy

1 of 6

PTCT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PTCT insiders and whales buy or sell their stock.

PTCT Shareholders

What type of owners hold Ptc Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Wellington Management Group LLP12.80%9,816,603$280.46MInstitution
Vanguard Group Inc11.47%8,800,843$251.44MInstitution
Blackrock Inc9.95%7,634,122$218.11MInstitution
Rtw Investments LP9.68%7,423,970$212.10MInstitution
Armistice Capital LLC8.95%6,864,000$196.10MInstitution
State Street Corp6.04%4,633,955$132.39MInstitution
Camber Capital Management LP5.22%4,000,000$114.28MInstitution
Michael Schmertzler4.91%3,766,742$107.62MInsider
Cowen And Company LLC4.86%3,725,626$106.44MInstitution
Janus Henderson Group PLC3.41%2,612,593$74.64MInstitution

1 of 3

PTCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTCT85.74%14.26%Net SellingNet Selling
ARVN74.74%25.26%Net SellingNet Selling
VERA55.23%44.77%Net SellingNet Selling
VCEL91.22%8.78%Net SellingNet Selling
DNLI56.52%43.48%Net SellingNet Selling

Ptc Therapeutics Stock Ownership FAQ

Who owns Ptc Therapeutics?

Ptc Therapeutics (NASDAQ: PTCT) is owned by 110.34% institutional shareholders, 18.35% Ptc Therapeutics insiders, and 0.00% retail investors. Michael Schmertzler is the largest individual Ptc Therapeutics shareholder, owning 3.77M shares representing 4.91% of the company. Michael Schmertzler's Ptc Therapeutics shares are currently valued at $107.62M.

If you're new to stock investing, here's how to buy Ptc Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.